Stay updated on Alirocumab Vascular Effects in AMI Clinical Trial
Sign up to get notified when there's something new on the Alirocumab Vascular Effects in AMI Clinical Trial page.
Latest updates to the Alirocumab Vascular Effects in AMI Clinical Trial page
- Check4 days agoChange DetectedFooter updates remove the HHS Vulnerability Disclosure link and add Revision: v3.3.3 (replacing v3.3.2); core study information and page functionality remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedMinor UI revision: the page now shows a Revision: v3.3.2 instead of the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check39 days agoChange DetectedRemoved the government funding lapse notice and its operating-status guidance from the page.SummaryDifference0.7%
- Check54 days agoChange DetectedNo substantive updates were detected; the study record content and status appear unchanged, with only minor UI/visual adjustments between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check82 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous version v3.1.0.SummaryDifference12%
- Check89 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%
Stay in the know with updates to Alirocumab Vascular Effects in AMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab Vascular Effects in AMI Clinical Trial page.